Istari Oncology Revenue and Competitors
Estimated Revenue & Valuation
- Istari Oncology's estimated annual revenue is currently $2.3M per year.
- Istari Oncology's estimated revenue per employee is $155,000
Employee Data
- Istari Oncology has 15 Employees.
- Istari Oncology grew their employee count by -25% last year.
Istari Oncology Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.2M | 72 | -13% | N/A | N/A |
#2 | $5099.8M | 32902 | -4% | N/A | N/A |
#3 | $1.7M | 11 | 0% | N/A | N/A |
#4 | $0.6M | 4 | -56% | N/A | N/A |
#5 | $0.9M | 11 | -39% | N/A | N/A |
#6 | $1.7M | 11 | 10% | N/A | N/A |
#7 | $0.6M | 4 | -33% | N/A | N/A |
#8 | $6.4M | 41 | 3% | N/A | N/A |
#9 | $4.2M | 27 | -18% | N/A | N/A |
#10 | $0.8M | 5 | 0% | N/A | N/A |
What Is Istari Oncology?
Istari Oncology, Inc. is a clinical-stage biotechnology company focused on novel immuno-oncology and immunotherapy platforms for the treatment of glioblastoma and a wide variety of tumors. The company was founded by Darell Bigner, MD, and Matthias Gromeier, MD, of Duke University Medical Center in 2016. Both are leaders in their respective research fields of virology, immunology, monoclonal development and clinical medicine, particularly in the treatment of brain tumors.
keywords:N/A
N/A
Total Funding
15
Number of Employees
$2.3M
Revenue (est)
-25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Morrisville
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.8M | 15 | N/A | N/A |
#2 | $1.8M | 15 | -37% | N/A |
#3 | $1.3M | 15 | N/A | N/A |
#4 | $7.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | 143% | N/A |